To increase the statistical power for the sensitivity estimates of p16/Ki-67, multi-center hospital-based recruitment was undertaken and a large number of women diagnosed with CIN2+ (n = 231, including 70 cervical cancer cases) were enrolled from the ongoing cervical cancer screening program or colposcopy clinic. This evidence concerns the gene CDKN2A and cervical carcinoma.